Entities / Company
LeMaitre Vascular (United States).
company in Burlington, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Earlier this month
Gone quiet
No new reports in 90+ days-
LeMaitre Vascular's Return on Capital Employed (ROCE) was reported to be around the industry average.Speculative1 report
-
LeMaitre Vascular stock experienced a significant price movement on NASDAQGM on August 1, 2025.Some support1 report
-
LeMaitre Vascular faces challenges including the discontinuation of ASIO, which impacted revenues, and the fallout from a catheter recall.Some support1 report
-
LeMaitre Vascular reported that it outperformed the industry growth forecast.Some support2 reports
-
LeMaitre Vascular reported that its Return on Equity (ROE) was similar to the industry average of 11% as of September 4, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around LeMaitre Vascular (United States) this week
News at the entities that move LeMaitre Vascular (United States) most-
ASIO StructuralAnthony Albanese confirmed that Helen Haines was attacked, leading to investigations by the AFP and ASIO.Moves LeMaitre Vascular (United States)
Connections
The 1 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
ASIO Structural
ASIO's discontinuation led to a decrease in LeMaitre Vascular's reported revenues.
History
Events by the month they beganJune 2026
6 events- Trump's pledge to unleash oil and gas benefits US stocks, involving LeMaitre Vascular.
- LeMaitre Vascular's Return on Capital Employed (ROCE) was reported to be around the industry average.
- LeMaitre Vascular stock experienced a significant price movement on NASDAQGM on August 1, 2025.
- LeMaitre Vascular faces challenges including the discontinuation of ASIO, which impacted revenues, and the fallout from a catheter recall.
- LeMaitre Vascular reported that it outperformed the industry growth forecast.
- LeMaitre Vascular reported that its Return on Equity (ROE) was similar to the industry average of 11% as of September 4, 2025.